ID: ALA3707025

Max Phase: Preclinical

Molecular Formula: C23H23N3O2

Molecular Weight: 373.46

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)c1c(N2CCN(C)CC2)nc2cccc3c2c1-c1ccccc1-3

Standard InChI:  InChI=1S/C23H23N3O2/c1-3-28-23(27)21-20-17-8-5-4-7-15(17)16-9-6-10-18(19(16)20)24-22(21)26-13-11-25(2)12-14-26/h4-10H,3,11-14H2,1-2H3

Standard InChI Key:  RDIIVORDQKRPBM-UHFFFAOYSA-N

Associated Targets(non-human)

Serotonin 3 (5-HT3) receptor 1834 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 373.46Molecular Weight (Monoisotopic): 373.1790AlogP: 3.81#Rotatable Bonds: 3
Polar Surface Area: 45.67Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.57CX LogP: 4.36CX LogD: 3.97
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.51Np Likeness Score: -0.68

References

1. Cappelli A, Anzini M, Vomero S, Canullo L, Mennuni L, Makovec F, Doucet E, Hamon M, Menziani MC, De Benedetti PG, Bruni G, Romeo MR, Giorgi G, Donati A..  (1999)  Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.,  42  (9): [PMID:10229626] [10.1021/jm981112s]

Source